| Literature DB >> 28188836 |
Weverson Luciano Pires1, Onassis Boeri de Castro1, Anderson Makoto Kayano2, Sulamita da Silva Setúbal1, Adriana Silva Pontes1, Neriane Monteiro Nery1, Mauro Valentino Paloschi1, Soraya Dos Santos Pereira3, Rodrigo Guerino Stábeli4, Carla Freire Celedônio Fernandes5, Andreimar Martins Soares4, Juliana Pavan Zuliani6.
Abstract
BjcuL is a C-type lectin with specificity for the binding of β-d-galactose units isolated from Bothrops jararacussu venom. It triggers cellular infiltration in post capillary venules, increases edema and vascular permeability in murine models, contributes to in vitro neutrophil activation and modulates macrophage functional activation towards an M1 state. The purpose of this study was to investigate the effect of BjcuL on human peripheral blood mononuclear cells (PBMCs) activation with a focus on PBMCs proliferation and inflammatory mediators release. Results showed that BjcuL is not toxic to PBMCs, that BjcuL inhibits PBMCs proliferation and that it stimulates PBMCs to produce superoxide anion and hydrogen peroxide, primarily via lymphocyte stimulation, but does not stimulate the production of nitric oxide and PGE2. These results demonstrate that BjcuL has an immunomodulatory effect on PBMCs. Further studies are needed to confirm the immunomodulatory effect of BjcuL, to elucidate the molecular mechanisms of action responsible for its effects and to determine its potential application as an immunopharmacological and biotechnological tool.Entities:
Keywords: Lectin; Mediators; PBMCs; Snake venom
Mesh:
Substances:
Year: 2017 PMID: 28188836 DOI: 10.1016/j.tiv.2017.02.003
Source DB: PubMed Journal: Toxicol In Vitro ISSN: 0887-2333 Impact factor: 3.500